Teriflunomide Market, Global Outlook and Forecast 2022-2028

January 2022 | 68 pages | ID: T1701E5FFC21EN
Market Monitor Global

Abstracts

Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.

This report contains market size and forecasts of Teriflunomide in Global, including the following market information:

Global Teriflunomide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Teriflunomide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Teriflunomide include Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals and Msn Laboratories Private Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Teriflunomide companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Teriflunomide Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Teriflunomide Market Segment Percentages, by Type, 2021 (%)

• Tablets
• Powder

Global Teriflunomide Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Teriflunomide Market Segment Percentages, by Application, 2021 (%)

• Immunosuppression
• Cancer Treatment

Global Teriflunomide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Teriflunomide Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Teriflunomide revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Teriflunomide revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi Aventis
• Genzyme Corporation
• Amneal Pharmaceuticals NY LC
• Glenmark Pharmaceuticals
• Msn Laboratories Private Limited

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Teriflunomide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Teriflunomide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TERIFLUNOMIDE OVERALL MARKET SIZE

2.1 Global Teriflunomide Market Size: 2021 VS 2028
2.2 Global Teriflunomide Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Teriflunomide Players in Global Market
3.2 Top Global Teriflunomide Companies Ranked by Revenue
3.3 Global Teriflunomide Revenue by Companies
3.4 Top 3 and Top 5 Teriflunomide Companies in Global Market, by Revenue in 2021
3.5 Global Companies Teriflunomide Product Type
3.6 Tier 1, Tier 2 and Tier 3 Teriflunomide Players in Global Market
  3.6.1 List of Global Tier 1 Teriflunomide Companies
  3.6.2 List of Global Tier 2 and Tier 3 Teriflunomide Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Teriflunomide Market Size Markets, 2021 & 2028
  4.1.2 Tablets
  4.1.3 Powder
4.2 By Type - Global Teriflunomide Revenue & Forecasts
  4.2.1 By Type - Global Teriflunomide Revenue, 2017-2022
  4.2.2 By Type - Global Teriflunomide Revenue, 2023-2028
  4.2.3 By Type - Global Teriflunomide Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Teriflunomide Market Size, 2021 & 2028
  5.1.2 Immunosuppression
  5.1.3 Cancer Treatment
5.2 By Application - Global Teriflunomide Revenue & Forecasts
  5.2.1 By Application - Global Teriflunomide Revenue, 2017-2022
  5.2.2 By Application - Global Teriflunomide Revenue, 2023-2028
  5.2.3 By Application - Global Teriflunomide Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Teriflunomide Market Size, 2021 & 2028
6.2 By Region - Global Teriflunomide Revenue & Forecasts
  6.2.1 By Region - Global Teriflunomide Revenue, 2017-2022
  6.2.2 By Region - Global Teriflunomide Revenue, 2023-2028
  6.2.3 By Region - Global Teriflunomide Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Teriflunomide Revenue, 2017-2028
  6.3.2 US Teriflunomide Market Size, 2017-2028
  6.3.3 Canada Teriflunomide Market Size, 2017-2028
  6.3.4 Mexico Teriflunomide Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Teriflunomide Revenue, 2017-2028
  6.4.2 Germany Teriflunomide Market Size, 2017-2028
  6.4.3 France Teriflunomide Market Size, 2017-2028
  6.4.4 U.K. Teriflunomide Market Size, 2017-2028
  6.4.5 Italy Teriflunomide Market Size, 2017-2028
  6.4.6 Russia Teriflunomide Market Size, 2017-2028
  6.4.7 Nordic Countries Teriflunomide Market Size, 2017-2028
  6.4.8 Benelux Teriflunomide Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Teriflunomide Revenue, 2017-2028
  6.5.2 China Teriflunomide Market Size, 2017-2028
  6.5.3 Japan Teriflunomide Market Size, 2017-2028
  6.5.4 South Korea Teriflunomide Market Size, 2017-2028
  6.5.5 Southeast Asia Teriflunomide Market Size, 2017-2028
  6.5.6 India Teriflunomide Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Teriflunomide Revenue, 2017-2028
  6.6.2 Brazil Teriflunomide Market Size, 2017-2028
  6.6.3 Argentina Teriflunomide Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Teriflunomide Revenue, 2017-2028
  6.7.2 Turkey Teriflunomide Market Size, 2017-2028
  6.7.3 Israel Teriflunomide Market Size, 2017-2028
  6.7.4 Saudi Arabia Teriflunomide Market Size, 2017-2028
  6.7.5 UAE Teriflunomide Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi Aventis
  7.1.1 Sanofi Aventis Corporate Summary
  7.1.2 Sanofi Aventis Business Overview
  7.1.3 Sanofi Aventis Teriflunomide Major Product Offerings
  7.1.4 Sanofi Aventis Teriflunomide Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Aventis Key News
7.2 Genzyme Corporation
  7.2.1 Genzyme Corporation Corporate Summary
  7.2.2 Genzyme Corporation Business Overview
  7.2.3 Genzyme Corporation Teriflunomide Major Product Offerings
  7.2.4 Genzyme Corporation Teriflunomide Revenue in Global Market (2017-2022)
  7.2.5 Genzyme Corporation Key News
7.3 Amneal Pharmaceuticals NY LC
  7.3.1 Amneal Pharmaceuticals NY LC Corporate Summary
  7.3.2 Amneal Pharmaceuticals NY LC Business Overview
  7.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Major Product Offerings
  7.3.4 Amneal Pharmaceuticals NY LC Teriflunomide Revenue in Global Market (2017-2022)
  7.3.5 Amneal Pharmaceuticals NY LC Key News
7.4 Glenmark Pharmaceuticals
  7.4.1 Glenmark Pharmaceuticals Corporate Summary
  7.4.2 Glenmark Pharmaceuticals Business Overview
  7.4.3 Glenmark Pharmaceuticals Teriflunomide Major Product Offerings
  7.4.4 Glenmark Pharmaceuticals Teriflunomide Revenue in Global Market (2017-2022)
  7.4.5 Glenmark Pharmaceuticals Key News
7.5 Msn Laboratories Private Limited
  7.5.1 Msn Laboratories Private Limited Corporate Summary
  7.5.2 Msn Laboratories Private Limited Business Overview
  7.5.3 Msn Laboratories Private Limited Teriflunomide Major Product Offerings
  7.5.4 Msn Laboratories Private Limited Teriflunomide Revenue in Global Market (2017-2022)
  7.5.5 Msn Laboratories Private Limited Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Teriflunomide Market Opportunities & Trends in Global Market
Table 2. Teriflunomide Market Drivers in Global Market
Table 3. Teriflunomide Market Restraints in Global Market
Table 4. Key Players of Teriflunomide in Global Market
Table 5. Top Teriflunomide Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Teriflunomide Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Teriflunomide Revenue Share by Companies, 2017-2022
Table 8. Global Companies Teriflunomide Product Type
Table 9. List of Global Tier 1 Teriflunomide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Teriflunomide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Teriflunomide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Teriflunomide Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Teriflunomide Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Teriflunomide Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Teriflunomide Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Teriflunomide Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Teriflunomide Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Teriflunomide Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Teriflunomide Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Teriflunomide Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Teriflunomide Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Teriflunomide Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Teriflunomide Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Teriflunomide Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Teriflunomide Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Teriflunomide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Teriflunomide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Teriflunomide Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Teriflunomide Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Aventis Corporate Summary
Table 31. Sanofi Aventis Teriflunomide Product Offerings
Table 32. Sanofi Aventis Teriflunomide Revenue (US$, Mn), (2017-2022)
Table 33. Genzyme Corporation Corporate Summary
Table 34. Genzyme Corporation Teriflunomide Product Offerings
Table 35. Genzyme Corporation Teriflunomide Revenue (US$, Mn), (2017-2022)
Table 36. Amneal Pharmaceuticals NY LC Corporate Summary
Table 37. Amneal Pharmaceuticals NY LC Teriflunomide Product Offerings
Table 38. Amneal Pharmaceuticals NY LC Teriflunomide Revenue (US$, Mn), (2017-2022)
Table 39. Glenmark Pharmaceuticals Corporate Summary
Table 40. Glenmark Pharmaceuticals Teriflunomide Product Offerings
Table 41. Glenmark Pharmaceuticals Teriflunomide Revenue (US$, Mn), (2017-2022)
Table 42. Msn Laboratories Private Limited Corporate Summary
Table 43. Msn Laboratories Private Limited Teriflunomide Product Offerings
Table 44. Msn Laboratories Private Limited Teriflunomide Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Teriflunomide Segment by Type in 2021
Figure 2. Teriflunomide Segment by Application in 2021
Figure 3. Global Teriflunomide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Teriflunomide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Teriflunomide Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Teriflunomide Revenue in 2021
Figure 8. By Type - Global Teriflunomide Revenue Market Share, 2017-2028
Figure 9. By Application - Global Teriflunomide Revenue Market Share, 2017-2028
Figure 10. By Region - Global Teriflunomide Revenue Market Share, 2017-2028
Figure 11. By Country - North America Teriflunomide Revenue Market Share, 2017-2028
Figure 12. US Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Teriflunomide Revenue Market Share, 2017-2028
Figure 16. Germany Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 17. France Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Teriflunomide Revenue Market Share, 2017-2028
Figure 24. China Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 28. India Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Teriflunomide Revenue Market Share, 2017-2028
Figure 30. Brazil Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Teriflunomide Revenue Market Share, 2017-2028
Figure 33. Turkey Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Teriflunomide Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Aventis Teriflunomide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Genzyme Corporation Teriflunomide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amneal Pharmaceuticals NY LC Teriflunomide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Glenmark Pharmaceuticals Teriflunomide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Msn Laboratories Private Limited Teriflunomide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)